Abstract
Opioid analgesics remain the most effective and widely used analgesics for the management of moderate to severe pain, including cancer pain and chronic non-cancer pain. However, the efficacy of long-term opioid analgesics is attenuated by tolerance and/or hyperalgesia after long-term use, preventing adequate pain relief under stable opioid dosages for chronic pain patients. Classical neuron-centered concepts about tolerance, such as internalization of opioid receptors, upregulation of N-methyl-D-aspartate receptor function, or downregulation of glutamate transporter activity, can only partially explain the phenomenon of tolerance. Recent evidence revealing glial activation and upregulation of inflammatory mediators in the rodent central nervous system has confirmed the pivotal role of neuroinflammation in neuropathic pain or opioid tolerance, or both. However, human evidence is still sparse.
Based on our clinical practice, we conducted translational research by investigating the cerebrospinal fluid (CSF) cytokine and chemokine profiles of opioid-tolerant patients after research ethic committee approval. CSF samples from opioid-tolerant patients and opioid-naive subjects were compared. We found CXCL1, CXCL12, and leukemia inhibitory factor (LIF) were significantly upregulated among the opioid-tolerant patients and positively correlated with the opioid dosage.
We translated these findings back to lab animal experiment; after induction of tolerance by morphine infusion, the spinal cord expression of CXCL1, CXCL12, and LIF were all upregulated. Although CXCL1 and CXCL12 infusion alone did not affect baseline tail-flick latency, morphine analgesic efficacy dropped significantly after intrathecal infusion of CXCL1 and CXCL12. After establishing tolerance by intrathecal continuous infusion of morphine, tolerance development was accelerated by co-administration of CXCL1 and CXCL12. In parallel, the effect was attenuated by co-administration of CXCL1- or CXCL12-neutralizing antibody or concordant receptor antagonists.
On the contrary, although chronic morphine administration still induced LIF upregulation in rat spinal cords, intrathecal injection of LIF potentiated the analgesic action of morphine and delayed the development of morphine tolerance. Upregulation of endogenously released LIF by long-term use of opioids might counterbalance the tolerance induction effects of other pro-inflammatory cytokines.
CXCL1, CXCL12, and LIF are upregulated in both opioid-tolerant patients and rodents. The onset and extent of opioid tolerance were affected by modulating the intrathecal CXCL1/CXCR2, CXCL12/CXCR4, and LIF signaling and could be novel drug targets for the treatment of opioid tolerance.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Al-Hasani R, Bruchas MR (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115(6):1363–1381. https://doi.org/10.1097/ALN.0b013e318238bba6
Beitner-Johnson D, Guitart X, Nestler EJ (1993) Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem 61(5):1766–1773
Berta T, Liu T, Liu YC, Xu ZZ, Ji RR (2012) Acute morphine activates satellite glial cells and up-regulates IL-1beta in dorsal root ganglia in mice via matrix metalloprotease-9. Mol Pain 8:18. https://doi.org/10.1186/1744-8069-8-18
Bhangoo SK, Ripsch MS, Buchanan DJ, Miller RJ, White FA (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 5:48. https://doi.org/10.1186/1744-8069-5-48
Chapman CR, Lipschitz DL, Angst MS, Chou R, Denisco RC, Donaldson GW, … Weisner CM (2010) Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base. J Pain 11(9):807–829. doi:https://doi.org/10.1016/j.jpain.2010.02.019
Che X, Ye W, Panga L, Wu DC, Yang GY (2001) Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902(2):171–177
Clark AK, Old EA, Malcangio M (2013) Neuropathic pain and cytokines: current perspectives. J Pain Res 6:803–814. https://doi.org/10.2147/JPR.S53660
Cui Y, Liao XX, Liu W, Guo RX, Wu ZZ, Zhao CM, … Feng JQ (2008) A novel role of minocycline: attenuating morphine antinociceptive tolerance by inhibition of p38 MAPK in the activated spinal microglia. Brain Behav Immun 22(1):114–123. doi:https://doi.org/10.1016/j.bbi.2007.07.014
Dubovy P, Klusakova I, Svizenska I, Brazda V (2010) Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain. Histochem Cell Biol 133(3):323–337. https://doi.org/10.1007/s00418-010-0675-0
Engert S, Wendland JR, Schwab A, Petersen M (2008) Leukemia inhibitory factor differentially regulates capsaicin and heat sensitivity in cultured rat dorsal root ganglion neurons. Neuropeptides 42(2):193–197. https://doi.org/10.1016/j.npep.2007.12.005
Flugel A, Hager G, Horvat A, Spitzer C, Singer GM, Graeber MB et al (2001) Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab 21(1):69–76. https://doi.org/10.1097/00004647-200101000-00009
Franciotta D, Zardini E, Ravaglia S, Piccolo G, Andreoni L, Bergamaschi R et al (2006) Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci 247(2):202–207. https://doi.org/10.1016/j.jns.2006.05.049
Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ et al (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 29(13):4096–4108. https://doi.org/10.1523/JNEUROSCI.3623-08.2009
Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, … Ren K (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27(22):6006–6018. doi:https://doi.org/10.1523/JNEUROSCI.0176-07.2007
Hendriks JJ, Slaets H, Carmans S, de Vries HE, Dijkstra CD, Stinissen P, Hellings N (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204(1–2):52–57. https://doi.org/10.1016/j.jneuroim.2008.07.015
Horvath RJ, DeLeo JA (2009) Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J Neurosci 29(4):998–1005. https://doi.org/10.1523/JNEUROSCI.4595-08.2009
Hu XM, Liu YN, Zhang HL, Cao SB, Zhang T, Chen LP, Shen W (2015) CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats. J Neurochem 132(4):452–463. https://doi.org/10.1111/jnc.12985
Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL et al (2008) Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav Immun 22(8):1248–1256. https://doi.org/10.1016/j.bbi.2008.07.008
Hutchinson MR, Shavit Y, Grace PM, Rice KC, Maier SF, Watkins LR (2011) Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol Rev 63(3):772–810. https://doi.org/10.1124/pr.110.004135
Johnson EA, Dao TL, Guignet MA, Geddes CE, Koemeter-Cox AI, Kan RK (2011) Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation 8:41. https://doi.org/10.1186/1742-2094-8-41
Johnson JL, Rolan PE, Johnson ME, Bobrovskaya L, Williams DB, Johnson K et al (2014) Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation. Transl Psychiatry 4:e482. https://doi.org/10.1038/tp.2014.121
Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J et al (2004) A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 24(33):7353–7365. https://doi.org/10.1523/JNEUROSCI.1850-04.2004
Juni A, Klein G, Pintar JE, Kest B (2007) Nociception increases during opioid infusion in opioid receptor triple knock-out mice. Neuroscience 147(2):439–444. https://doi.org/10.1016/j.neuroscience.2007.04.030
Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14(2):145–161
Lilius TO, Rauhala PV, Kambur O, Kalso EA (2009) Modulation of morphine-induced antinociception in acute and chronic opioid treatment by ibudilast. Anesthesiology 111(6):1356–1364. https://doi.org/10.1097/ALN.0b013e3181bdfa11
Lin CP, Kang KH, Lin TH, Wu MY, Liou HC, Chuang WJ et al (2015) Role of spinal CXCL1 (GROalpha) in opioid tolerance: a human-to-rodent translational study. Anesthesiology 122(3):666–676. https://doi.org/10.1097/ALN.0000000000000523
Lin CP, Kang KH, Tu HJ, Wu MY, Lin TH, Liou HC et al (2017) CXCL12/CXCR4 Signaling contributes to the pathogenesis of opioid tolerance: a translational study. Anesth Analg 124(3):972–979. https://doi.org/10.1213/ANE.0000000000001480
Luo X, Tai WL, Sun L, Qiu Q, Xia Z, Chung SK, Cheung CW (2014) Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice. PLoS One 9(8):e104860. https://doi.org/10.1371/journal.pone.0104860
Mao J, Price DD, Mayer DJ (1994) Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci 14(4):2301–2312
Menichella DM, Abdelhak B, Ren D, Shum A, Frietag C, Miller RJ (2014) CXCR4 chemokine receptor signaling mediates pain in diabetic neuropathy. Mol Pain 10:42. https://doi.org/10.1186/1744-8069-10-42
Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10(1):23–36. https://doi.org/10.1038/nrn2533
Narita M, Mizoguchi H, Narita M, Nagase H, Suzuki T, Tseng LF (2001) Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)] enkephalin. J Neurosci 21(11):3715–3720
Okie S (2010) A flood of opioids, a rising tide of deaths. N Engl J Med 363(21):1981–1985. https://doi.org/10.1056/NEJMp1011512
Pertovaara A, Wei H (2001) Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. Eur J Pharmacol 429(1–3):139–145
Pranzatelli MR, Tate ED, McGee NR, Colliver JA (2013) Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders. J Neurol Sci 326(1–2):53–58. https://doi.org/10.1016/j.jns.2013.01.011
Raghavendra V, Rutkowski MD, DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 22(22):9980–9989
Raghavendra V, Tanga FY, DeLeo JA (2004) Attenuation of morphine tolerance, withdrawal-induced hyperalgesia, and associated spinal inflammatory immune responses by propentofylline in rats. Neuropsychopharmacology 29(2):327–334. https://doi.org/10.1038/sj.npp.1300315
Reaux-Le Goazigo A, Rivat C, Kitabgi P, Pohl M, Melik Parsadaniantz S (2012) Cellular and subcellular localization of CXCL12 and CXCR4 in rat nociceptive structures: physiological relevance. Eur J Neurosci 36(5):2619–2631. https://doi.org/10.1111/j.1460-9568.2012.08179.x
Reaux-Le Goazigo A, Van Steenwinckel J, Rostene W, Melik Parsadaniantz S (2013) Current status of chemokines in the adult CNS. Prog Neurobiol 104:67–92. https://doi.org/10.1016/j.pneurobio.2013.02.001
Rivat C, Sebaihi S, Van Steenwinckel J, Fouquet S, Kitabgi P, Pohl M et al (2014) Src family kinases involved in CXCL12-induced loss of acute morphine analgesia. Brain Behav Immun 38:38–52. https://doi.org/10.1016/j.bbi.2013.11.010
Shavit Y, Wolf G, Goshen I, Livshits D, Yirmiya R (2005) Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 115(1–2):50–59. https://doi.org/10.1016/j.pain.2005.02.003
Shen CH, Tsai RY, Shih MS, Lin SL, Tai YH, Chien CC, Wong CS (2011) Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Anesth Analg 112(2):454–459. https://doi.org/10.1213/ANE.0b013e3182025b15
Shen CH, Tsai RY, Wong CS (2012) Role of neuroinflammation in morphine tolerance: effect of tumor necrosis factor-alpha. Acta Anaesthesiol Taiwanica 50(4):178–182. https://doi.org/10.1016/j.aat.2012.12.004
Shen W, Hu XM, Liu YN, Han Y, Chen LP, Wang CC, Song C (2014) CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord. J Neuroinflammation 11:75. https://doi.org/10.1186/1742-2094-11-75
Simamura E, Shimada H, Higashi N, Uchishiba M, Otani H, Hatta T (2010) Maternal leukemia inhibitory factor (LIF) promotes fetal neurogenesis via a LIF-ACTH-LIF signaling relay pathway. Endocrinology 151(4):1853–1862. https://doi.org/10.1210/en.2009-0985
Song P, Zhao ZQ (2001) The involvement of glial cells in the development of morphine tolerance. Neurosci Res 39(3):281–286
Spofford CM, Mohan S, Kang S, Jang JH, Brennan TJ (2011) Evaluation of leukemia inhibitory factor (LIF) in a rat model of postoperative pain. J Pain 12(7):819–832. https://doi.org/10.1016/j.jpain.2011.02.351
Stein C, Reinecke H, Sorgatz H (2010) Opioid use in chronic noncancer pain: guidelines revisited. Curr Opin Anaesthesiol 23(5):598–601. https://doi.org/10.1097/ACO.0b013e32833c57a8
Stein C, Schafer M, Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9(8):1003–1008. https://doi.org/10.1038/nm908
Tai YH, Wang YH, Wang JJ, Tao PL, Tung CS, Wong CS (2006) Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain 124(1–2):77–86. https://doi.org/10.1016/j.pain.2006.03.018
Trujillo KA, Akil H (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251(4989):85–87
Tu HJ, Kang KH, Ho SY, Liou HC, Liou HH, Lin CP, Fu WM (2016) Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids. Br J Anaesth 117(4):512–520. https://doi.org/10.1093/bja/aew247
Wen YR, Tan PH, Cheng JK, Liu YC, Ji RR (2011) Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc 110(8):487–494. https://doi.org/10.1016/S0929-6646(11)60074-0
White FA, Bhangoo SK, Miller RJ (2005a) Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 4(10):834–844. https://doi.org/10.1038/nrd1852
White FA, Jung H, Miller RJ (2007) Chemokines and the pathophysiology of neuropathic pain. Proc Natl Acad Sci U S A 104(51):20151–20158. https://doi.org/10.1073/pnas.0709250104
White FA, Sun J, Waters SM, Ma C, Ren D, Ripsch M et al (2005b) Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A 102(39):4092–14097. https://doi.org/10.1073/pnas.0503496102
Wilson NM, Jung H, Ripsch MS, Miller RJ, White FA (2011) CXCR4 signaling mediates morphine-induced tactile hyperalgesia. Brain Behav Immun 25(3):565–573. https://doi.org/10.1016/j.bbi.2010.12.014
Zhang ZJ, Cao DL, Zhang X, Ji RR, Gao YJ (2013) Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain 154(10):2185–2197. https://doi.org/10.1016/j.pain.2013.07.002
Zhao CM, Guo RX, Hu F, Meng JL, Mo LQ, Chen PX et al (2012) Spinal MCP-1 contributes to the development of morphine antinociceptive tolerance in rats. Am J Med Sci 344(6):473–479. https://doi.org/10.1097/MAJ.0b013e31826a82ce
Zhou L, Zhang Q, Stein C, Schafer M (1998) Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 286(2):1000–1006
Zwijnenburg PJ, de Bie HM, Roord JJ, van der Poll T, van Furth AM (2003) Chemotactic activity of CXCL5 in cerebrospinal fluid of children with bacterial meningitis. J Neuroimmunol 145(1–2):148–153
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Lin, CP., Lu, DH. (2018). Role of Neuroinflammation in Opioid Tolerance: Translational Evidence from Human-to-Rodent Studies. In: Shyu, BC., Tominaga, M. (eds) Advances in Pain Research: Mechanisms and Modulation of Chronic Pain. Advances in Experimental Medicine and Biology, vol 1099. Springer, Singapore. https://doi.org/10.1007/978-981-13-1756-9_11
Download citation
DOI: https://doi.org/10.1007/978-981-13-1756-9_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1755-2
Online ISBN: 978-981-13-1756-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)